Literature DB >> 7753552

Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.

A D Brown1, D Lopez-Terrada, C Denny, K A Lee.   

Abstract

Chromosomal translocations that fuse the N-terminal region of the Ewings sarcoma oncogene (EWS) to the C-terminal region (including the DNA-binding domain) of the cellular transcription factor ATF1 are associated with a tumour type termed malignant melanoma of soft parts (MMSP). It is envisioned that transformation by the EWS/ATF1 fusion protein results from aberrant transcriptional regulation of genes that are normally regulated by ATF1. To examine this hypothesis we have expressed exogenous EWS-ATF1 in JEG3 cells and tested its ability to activate several promoters that contain binding sites for ATF1. We show that EWS-ATF1 is a strong constitutive activator of some promoters tested but represses others. Significantly, the ability of particular promoters to be activated by EWS/ATF1 in JEG3 cells correlates with promoter activity in two MMSP-derived cell lines (SU-CCS-1 and DTC1). Our results therefore provide evidence that endogenous EWS/ATF1 can de-regulate transcription and that this capacity may contribute to transformation in MMSP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753552

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Authors:  Kangdong Liu; Yong-Yeon Cho; Ke Yao; Janos Nadas; Dong Joon Kim; Eun-Jin Cho; Mee-Hyun Lee; Angelo Pugliese; Jishuai Zhang; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Authors:  Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

4.  A transcription assay for EWS oncoproteins in Xenopus oocytes.

Authors:  King Pan Ng; Felix Cheung; Kevin A W Lee
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

5.  RGG boxes within the TET/FET family of RNA-binding proteins are functionally distinct.

Authors:  Bess Ling Chau; King Pan Ng; Kim K C Li; Kevin A W Lee
Journal:  Transcription       Date:  2016-05-09

6.  EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.

Authors:  Kazunari Yamada; Takatoshi Ohno; Hitomi Aoki; Katsunori Semi; Akira Watanabe; Hiroshi Moritake; Shunichi Shiozawa; Takahiro Kunisada; Yukiko Kobayashi; Junya Toguchida; Katsuji Shimizu; Akira Hara; Yasuhiro Yamada
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

7.  Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.

Authors:  Satoru Yokoyama; Erez Feige; Laura L Poling; Carmit Levy; Hans R Widlund; Mehdi Khaled; Andrew L Kung; David E Fisher
Journal:  Pigment Cell Melanoma Res       Date:  2008-06-27       Impact factor: 4.693

8.  The EWS-Oct-4 fusion gene encodes a transforming gene.

Authors:  Jungwoon Lee; Ja Young Kim; In Young Kang; Hye Kyoung Kim; Yong-Mahn Han; Jungho Kim
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

9.  Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.

Authors:  Ian J Davis; Andrew W McFadden; Yixiang Zhang; Angela Coxon; Teresa L Burgess; Andrew J Wagner; David E Fisher
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

10.  Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.

Authors:  Marimu Sakumoto; Rieko Oyama; Mami Takahashi; Yoko Takai; Fusako Kito; Kumiko Shiozawa; Zhiwei Qiao; Makoto Endo; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.